RESMED INC — Director's Dealing 2016

Dec 12, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2016-12-09

Reporting Person: FARRELL PETER C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-12-09	ResMed Common Stock	G	34400	$61.71	Disposed	318007	Direct

Footnotes

F1: The transaction represents a gift to the Farrell Family Foundation, a 501(c)(3) non-profit corporation. Dr. Farrell has no beneficial interest, control or dispositive power over the gifted shares.

F2: This transaction was executed in multiple trades at prices ranging from $61.18 to $62.24. The price reported above represents the weighted average sales price.